Overview

Allergy Patch Tests Market Introduction

Allergy Patch Test Market is forecasted to grow at a CAGR of over 7% during the forecast period, 2022 to 2028.

Patch testing is a process to identify allergic contact dermatitis and it involves applying patches with test substances in small cubes or discs to a person back. The patches are protected with hypoglycemic tapes. No needle pricking is involved. Patch test does not test for hives or food allergy. There are some drawbacks with these patches includes the appearance of darker skin after treatment, sometime rash may be reactivated and it became widespread. This test can be used for atopic dermatitis, eczema, etc.

Increasing prevalence of allergic contact dermatitis among the general population led to the robust growth of the market. Dermatitis is associated with serious complications and it requires continuous management. Diagnosis is prerequisite for proper management of dermatitis and it fuelled the growth of the market. An allergy patch test is simple, cost-effective and improves the compliance of patients. Further, the growing awareness of allergic reactions among the general population is expected to fuel the growth of the market. Along with this, the rapid evolution of technologies led to further innovation of existing portfolios. Manufactures are more focused on product line extensions in order to gain market share in international markets.

The global market is dominated by North America due to high awareness and high per capita healthcare expenditure. Europe is the second major shareholder of the global market due to the high prevalence of allergic reactions. The Asia Pacific represents a high opportunistic market for both domestic and international manufacturers due to the rising incidence of allergic reactions. It expected to register the highest growth rate during the forecast period. It is followed by Latin America and Rest of the World, as they account small fraction due to a highly untapped market. It also represents opportunistic space for international players.

Allergy Patch Tests market players include:

• Chemotechnique MB Diagnostics AB
• Grupo Ferrer Internacional, S.A.
• Mekos Laboratories ApS
• Epitest Ltd
• Merck Millipore (Merck Group)

Allergy Patch Tests Market Segmentation

By Indications

Eczema
Drug Induced Exfoliative Dermatitis

By End User

Hospitals
Diagnostics Laboratories
Specialty Clinics

By Region

North America
Latin America
Europe
Asia Pacific
Rest of the World

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the global Allergy Patch Tests Market by indications, by end-user, and by Region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East
• To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
• Profiling of companies to evaluate their market shares, strategies, financials and core competencies